[go: up one dir, main page]

RU2006101681A - Смесь для детей первых месяцев жизни или старше - Google Patents

Смесь для детей первых месяцев жизни или старше Download PDF

Info

Publication number
RU2006101681A
RU2006101681A RU2006101681/13A RU2006101681A RU2006101681A RU 2006101681 A RU2006101681 A RU 2006101681A RU 2006101681/13 A RU2006101681/13 A RU 2006101681/13A RU 2006101681 A RU2006101681 A RU 2006101681A RU 2006101681 A RU2006101681 A RU 2006101681A
Authority
RU
Russia
Prior art keywords
mixture according
source
mixture
infant
cgmp
Prior art date
Application number
RU2006101681/13A
Other languages
English (en)
Other versions
RU2346448C2 (ru
Inventor
Мари-Кристин СЕКРЕТЕН (CH)
Мари-Кристин СЕКРЕТЕН
Original Assignee
Нестек С.А. (Ch)
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33522260&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RU2006101681(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Нестек С.А. (Ch), Нестек С.А. filed Critical Нестек С.А. (Ch)
Publication of RU2006101681A publication Critical patent/RU2006101681A/ru
Application granted granted Critical
Publication of RU2346448C2 publication Critical patent/RU2346448C2/ru

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747Lactobacilli, e.g. L. acidophilus or L. brevis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115Fatty acids or derivatives thereof; Fats or oils
    • A23L33/12Fatty acids or derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135Bacteria or derivatives thereof, e.g. probiotics
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/19Dairy proteins
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • A61K35/741Probiotics
    • A61K35/744Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745Bifidobacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/165Paracasei
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/11Lactobacillus
    • A23V2400/175Rhamnosus
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00Lactic or propionic acid bacteria
    • A23V2400/51Bifidobacterium
    • A23V2400/533Longum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pediatric Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (19)

1. Смесь для грудных детей первых месяцев жизни или старше, содержащая источник белков, источник липидов, источник углеводов и пробиотик, в которой источник липидов включает, по меньшей мере, одну LC-PUFA (длинноцепочечная полиненасыщенная жирная кислота).
2. Смесь по п.1, в которой LC-PUFA является DHA (докозагексаеновая кислота).
3. Смесь по п.2, в которой содержание DHA составляет от 0,2 до 0,5% от общего содержания жирных кислот в источнике липидов.
4. Смесь по п.2 или 3, которая дополнительно включает ARA (арахидоновая кислота).
5. Смесь по п.4, в которой отношение ARA:DHA составляет от 0,8:1 до 1,2:1, предпочтительно 1:1.
6. Смесь по п.1, в которой пробиотик представляет собой Bifidobacteria или Lactobacillus.
7. Смесь по п.6, в которой в качестве Bifidobacteria используют Bifidobacterium longum BB 536.
8. Смесь по п.6, в которой в качестве Lactobacillus используют Lactobacillus paracasei rhamnosus GG.
9. Смесь по п.6, которая содержит как Bifidobacterium, так и Lactobacillus.
10. Смесь по п.9, в которой в качестве Bifidobacteria используют Bifidobacterium longum BB 536, а в качестве Lactobacillus используют Lactobacillus paracasei rhamnosus GG.
11. Смесь по п.1, в которой, по меньшей мере, 40% белков составляют модифицированные белки сладкой (подсырной) сыворотки, не содержащие CGMP или содержащие пониженное количество CGMP.
12. Смесь по п.11, в которой, по меньшей мере, 60% белков составляют модифицированные белки сладкой сыворотки, не содержащие CGMP или содержащие пониженное количество CGMP.
13. Смесь по п.12, в которой белки присутствуют в максимальном относительном количестве 2 г/100 ккал, более предпочтительно 1,85, наиболее предпочтительно от 1,8 до 1,85 г/100 ккал.
14. Способ укрепления врожденной иммунной защиты грудного ребенка младшего или старшего возраста, заключающийся в полном или частичном кормлении указанного грудного ребенка младшего или старшего возраста смесью, содержащей источник белков, источник липидов, источник углеводов и пробиотик, в которой источник липидов включает, по меньшей мере, одну LC-PUFA.
15. Способ по п.14, использующий смесь по любому из пп.1-13.
16. Способ по п.14 или 15, характеризующийся сокращением случаев скопления газов в желудке и кишечнике, рвоты, срыгивания и/или болезненности.
17. Способ стимуляции здорового умственного развития грудного ребенка младшего или старшего возраста, заключающийся в полном или частичном кормлении указанного грудного ребенка младшего или старшего возраста смесью, содержащей источник белков, источник липидов, источник углеводов и пробиотик, в которой источник липидов включает, по меньшей мере, одну LC-PUFA и в которой, по меньшей мере, 40% белков составляют модифицированные белки сладкой сыворотки, не содержащие CGMP или содержащие пониженное количество CGMP.
18. Способ по п.17, использующий смесь по любому из пп.1-11.
19. Способ по п.17 или 18, в котором грудной ребенок является недоношенным.
RU2006101681/13A 2003-06-23 2004-06-18 Смесь для детей первых месяцев жизни или старше RU2346448C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03014056 2003-06-23
EP03014056.0 2003-06-23

Publications (2)

Publication Number Publication Date
RU2006101681A true RU2006101681A (ru) 2006-06-10
RU2346448C2 RU2346448C2 (ru) 2009-02-20

Family

ID=33522260

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2006101681/13A RU2346448C2 (ru) 2003-06-23 2004-06-18 Смесь для детей первых месяцев жизни или старше

Country Status (19)

Country Link
US (2) US20070031537A1 (ru)
EP (1) EP1638414B1 (ru)
CN (1) CN1838888B (ru)
AR (1) AR044867A1 (ru)
AT (1) ATE433674T1 (ru)
AU (1) AU2004248911B2 (ru)
CA (1) CA2532489C (ru)
CL (1) CL2004001550A1 (ru)
DE (1) DE602004021596D1 (ru)
ES (1) ES2326481T3 (ru)
MY (1) MY145116A (ru)
NO (1) NO20060350L (ru)
NZ (1) NZ544726A (ru)
PL (1) PL1638414T3 (ru)
PT (1) PT1638414E (ru)
RU (1) RU2346448C2 (ru)
TW (1) TWI421034B (ru)
WO (1) WO2004112507A1 (ru)
ZA (1) ZA200600601B (ru)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2521642C2 (ru) * 2008-10-20 2014-07-10 Нестек С.А. Питательная композиция с противосрыгивающими свойствами

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7572474B2 (en) * 2005-06-01 2009-08-11 Mead Johnson Nutrition Company Method for simulating the functional attributes of human milk oligosaccharides in formula-fed infants
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
US20070166411A1 (en) * 2005-12-16 2007-07-19 Bristol-Myers Squibb Company Nutritional supplement containing long-chain polyunsaturated fatty acids
CA2634693A1 (en) * 2005-12-23 2007-06-28 N.V. Nutricia Composition comprising polyunsaturated fatty acids, proteins and manganese and/or molybden for improving membrane composition
PT1800675E (pt) * 2005-12-23 2011-08-30 Nutricia Nv COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
MY148872A (en) 2006-02-15 2013-06-14 Nestec Sa Use of bifidobacterium longum for the prevention and treatment of inflammation
US7374924B2 (en) * 2006-06-05 2008-05-20 Biogaia Ab Use of selected lactic acid bacteria for reducing infantile colic
NL1033521C2 (nl) * 2007-03-08 2008-09-09 Friesland Brands Bv Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
EP1974734A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Probiotics for reduction of risk of obesity
EP1974735A1 (en) * 2007-03-28 2008-10-01 Nestec S.A. Reduction of risk of diarrhoea
WO2009000875A2 (en) * 2007-06-27 2008-12-31 Chr. Hansen A/S Lactobacillus helveticus bacterium composition for treatment of atopic dermatitis
BE1017714A5 (fr) * 2007-08-16 2009-04-07 Lidth De Jeude Jehan Van Composition de complement alimentaire pour femmes enceintes.
US8343753B2 (en) 2007-11-01 2013-01-01 Wake Forest University School Of Medicine Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
US9131721B2 (en) 2007-12-04 2015-09-15 Nestec S.A. Gut microbiota in infants
UA101176C2 (ru) * 2008-01-24 2013-03-11 Нестек С.А. Капсула для применения в устройстве для приготовления напитков, которая содержит питательные ингредиенты и способ получения питательной жидкости из капсулы
EP2348890B1 (en) 2008-03-28 2013-09-18 Nestec S.A. Probiotics for use in expecting female mammals for enhancing the immunity of their offsprings
EP2110027A1 (en) * 2008-04-01 2009-10-21 Nestec S.A. Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
EP2147678A1 (en) * 2008-07-21 2010-01-27 Nestec S.A. Probiotics to increase IgA secretion in infants born by caesarean section
US8498729B2 (en) 2008-08-29 2013-07-30 Smp Logic Systems Llc Manufacturing execution system for use in manufacturing baby formula
US8137718B2 (en) * 2008-09-19 2012-03-20 Mead Johnson Nutrition Company Probiotic infant products
US20100074870A1 (en) * 2008-09-19 2010-03-25 Bristol-Myers Squibb Company Probiotic infant products
EP2452574A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional formula with particularly adapted caloric density for young infants
WO2010110649A1 (en) * 2009-03-24 2010-09-30 N.V. Nutricia Stage 1 and stage 2 infant formula
RU2556124C2 (ru) * 2009-05-11 2015-07-10 Нестек С.А. Lactobacillus johnsonii La1 NСС533 (CNCM 1-1225) И ИММУННЫЕ НАРУШЕНИЯ
WO2010137944A1 (en) * 2009-05-27 2010-12-02 N.V. Nutricia Treatment of hypercalcaemia
EP2258217A1 (en) 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Children
EP2258216A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
EP2258218A1 (en) * 2009-06-02 2010-12-08 Nestec S.A. Nutritional Composition for Supporting Brain Development and Function of Toddlers
IN2012DN00282A (ru) * 2009-07-31 2015-05-08 Nestec Sa
EP2289527B1 (en) 2009-08-25 2018-02-21 Nestec S.A. Bifidobacterium longum and functional GI disorders
CN101637447B (zh) * 2009-08-31 2011-09-21 武汉武药科技有限公司 一种西他沙星注射剂及其制备方法
EP2295535A1 (en) * 2009-09-11 2011-03-16 Mead Johnson Nutrition Company Probiotic material
KR101889561B1 (ko) * 2009-11-03 2018-08-17 디에스엠 아이피 어셋츠 비.브이. 세포 및 20개 이상의 탄소 원자를 가진 다가불포화 지방산을 포함하는 조성물
MX355576B (es) 2010-04-26 2018-04-23 Enzymotec Ltd Metodos y composiciones de lipido para promover el desarrollo de la flora intestinal.
EP2404507A1 (en) * 2010-07-08 2012-01-11 Nestec S.A. Array of age-tailored nutritional formula with optimum fat content
IT1405395B1 (it) * 2010-08-05 2014-01-10 Proge Farm Srl Composizioni di probiotici e oli e loro uso.
EP2452575A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Array of age-tailored nutritional formula with probiotics
EP2452573A1 (en) * 2010-11-15 2012-05-16 Nestec S.A. Age-tailored nutritional composition with animal fats and vegetable fats
US9375028B2 (en) 2010-12-09 2016-06-28 Mead Johnson Nutrition Company Compositions and methods for nutrient delivery
US20120269929A1 (en) * 2011-04-22 2012-10-25 Hugh Lippman Fortified Milk-Based Nutritional Compositions
CN102845533A (zh) * 2011-06-27 2013-01-02 内蒙古蒙牛乳业(集团)股份有限公司 12到36个月幼儿营养干酪的生产方法
CN103874427A (zh) * 2011-07-12 2014-06-18 雀巢产品技术援助有限公司 为了提高对在断奶期期间新引入食物的耐受性对健康年幼哺乳动物施用的益生菌剂
BR112014008944B1 (pt) * 2011-10-18 2020-09-15 Société des Produits Nestlé S.A. Composição nutricional simbiótica compreendendo lc-pufa, probiótico e mistura de oligossacarídeos para crescimento cerebral e/ou desenvolvimento cognitivo e/ou psicomotor
WO2013187755A1 (en) * 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
RU2514346C1 (ru) * 2012-08-27 2014-04-27 Федеральное государственное казённое военное образовательное учреждение высшего профессионального образования Военно-медицинская академия имени С.М. Кирова Министерства обороны Российской Федерации (ВМедА) Способ лечения недоношенных новорожденных детей с низкой массой тела
RU2717339C2 (ru) * 2013-12-13 2020-03-23 Сосьете Де Продюи Нестле С.А. Применение содержащей сладкую молочную сыворотку детской смеси для обеспечения постнатального развития нервной системы желудочно-кишечного тракта младенца и формирования функций кишечника, которыми она управляет
US10517918B2 (en) 2013-12-13 2019-12-31 Societe Des Produits Nestle S.A. Use of a modified sweet whey and a modified sweet whey containing infant formula for promoting the postnatal development of the infant central nervous system and related cognitive functions
NL2015032B1 (en) * 2015-06-26 2017-01-24 Vitalnext B V Compositions and methods for the treatment of malnutrition.
US11986445B2 (en) * 2015-12-14 2024-05-21 Societe Des Produits Nestle S.A. Nutritional composition and infant formula for promoting myelination of the brain
US11197917B2 (en) 2017-12-01 2021-12-14 ByHeart, Inc. Formulations for nutritional support in subjects in need thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1346105A1 (ru) * 1985-12-05 1987-10-23 Киргизский Научно-Исследовательский Институт Акушерства И Педиатрии Способ получени молочного продукта дл питани детей первых мес цев жизни
DE3603000A1 (de) * 1986-01-31 1987-08-06 Milupa Ag Neue polyensaeure-reiche fettmischung und deren verwendung bei der herstellung von saeuglingsnahrungen
JP2731035B2 (ja) * 1991-01-24 1998-03-25 マーテック・コーポレイション 微生物油混合物およびその使用
US5902578A (en) * 1996-03-25 1999-05-11 Abbott Laboratories Method and formula for the prevention of diarrhea
PL343902A1 (en) * 1997-02-21 2001-09-10 Abbott Lab Methods of and compositions for reducing enteritis and colitis morbidity rate
CN1660065A (zh) * 1997-03-27 2005-08-31 布里斯托尔-迈尔斯斯奎布公司 二十二碳六烯酸和花生四烯酸促进不足月婴儿生长的用途
EP0880902A1 (fr) * 1997-05-27 1998-12-02 Nestlé Produkte AG Procédé de traitement d'une matiére première lactosérique
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
MXPA01010778A (es) * 1999-04-29 2003-08-20 Nestle Sa Composicion para una formula para infantes, que tiene un bajo contenido de treonina.
PT1048226E (pt) * 1999-04-29 2005-11-30 Nestle Sa Formula para lectentes que contem uma proteina de soro de leite doce
US6596302B2 (en) * 2000-04-13 2003-07-22 Abbott Laboratories Infant formulas containing long-chain polyunsaturated fatty acids and uses thereof
US6592863B2 (en) * 2000-08-22 2003-07-15 Nestec S.A. Nutritional composition
FI109602B (fi) * 2001-01-25 2002-09-13 Valio Oy Probioottiyhdistelmä
US20030077255A1 (en) * 2001-04-16 2003-04-24 Sabharwal Hemant K. Compositions of bacteria and alpha-lactalbumin and uses thereof
DE10219684A1 (de) * 2001-05-04 2002-11-14 Unternehmensberatung Reichenau Ernährungsprodukt, Pflegeprodukt und Herstellungsverfahren
US20030017192A1 (en) * 2001-06-19 2003-01-23 Hanny Kanafani Process for producing extended shelf-life ready-to-use milk compositions containing probiotics
US20030060509A1 (en) * 2001-08-24 2003-03-27 Elswyk Mary Van Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
DE20202562U1 (de) * 2002-02-19 2002-05-23 Orthomol pharmazeutische Vertriebs GmbH, 40764 Langenfeld Mikronährstoffkombinationsprodukt mit Pro- und Prebiotika

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2521642C2 (ru) * 2008-10-20 2014-07-10 Нестек С.А. Питательная композиция с противосрыгивающими свойствами

Also Published As

Publication number Publication date
EP1638414A1 (en) 2006-03-29
TW200507766A (en) 2005-03-01
CA2532489A1 (en) 2004-12-29
ATE433674T1 (de) 2009-07-15
PL1638414T3 (pl) 2009-12-31
CA2532489C (en) 2012-12-11
NZ544726A (en) 2009-05-31
PT1638414E (pt) 2009-07-13
CL2004001550A1 (es) 2005-06-03
ES2326481T3 (es) 2009-10-13
MY145116A (en) 2011-12-30
US20070031537A1 (en) 2007-02-08
DE602004021596D1 (de) 2009-07-30
WO2004112507A1 (en) 2004-12-29
CN1838888B (zh) 2016-02-17
NO20060350L (no) 2006-03-23
EP1638414B1 (en) 2009-06-17
RU2346448C2 (ru) 2009-02-20
US20110250317A1 (en) 2011-10-13
TWI421034B (zh) 2014-01-01
AU2004248911B2 (en) 2010-09-16
AU2004248911A1 (en) 2004-12-29
CN1838888A (zh) 2006-09-27
ZA200600601B (en) 2007-05-30
AR044867A1 (es) 2005-10-05

Similar Documents

Publication Publication Date Title
RU2006101681A (ru) Смесь для детей первых месяцев жизни или старше
RU2006101678A (ru) Смесь для детей первых месяцев жизни или старше
CN102186463B (zh) 促进健康发育与生长的营养组合物
US8377430B2 (en) Infant formula with probiotics
CN1863463A (zh) 用于最佳肠道屏障功能的营养配方
TW200946033A (en) Long-chain polyunsaturated fatty acids (LC-PUFA) in maternal nutrition during pregnancy and lactation
WO2010003790A1 (en) A nutritional composition with free amino acids and structured lipids
Markworth et al. Arachidonic acid supplementation modulates blood and skeletal muscle lipid profile with no effect on basal inflammation in resistance exercise trained men
ES2767600T3 (es) Fórmulas que comprenden perfiles de aminoácidos optimizados
ES2346912T3 (es) Formula infantil inmunologica.
RU2648375C2 (ru) Детская смесь с низким содержанием жирных кислот со средней длиной цепи в определенных пропорциях и ее применение при стимуляции и/или обеспечении сбалансированного роста грудных детей
Guillaume et al. Flatfish, turbot, sole, and plaice
CN102984957A (zh) 具有最佳脂肪含量的年龄特定的营养配方食品的排列
ES2738006T3 (es) Uso de Lactobacillus rhamnosus GG en combinación con un ácido graso poliinsaturado de cadena larga para el tratamiento, prevención o reducción de la inflamación sistémica en un lactante alimentado con leche maternizada
Ramena et al. Artemia Enrichment Strategies: A comprehensive review of nutritional enhancements with emphasis on fatty acid profiles in aquatic species
ES2974661T3 (es) Hidrolizado de proteínas de pescado azul
Bontempo et al. Feeding various fat sources to sows: effects on immune status and performance of sows and piglets
MX2007012530A (es) Uso de lactobacillus rhamnosus gg para el tratamiento, prevencion o reduccion de inflamacion sistemica en un infante que se alimenta con formula.
US20220000164A1 (en) Nutritional compositions, their use in reducing metabolic stress and method of reducing metabolic stress
Bontempo et al. 16. Feeding various fat sources to sows: effects on immune status and performance of sows and piglets
HK1091379A (en) Infant or follow-on formula
HK1161840B (en) Nutritional composition to promote healthy development and growth
HK1090258A (en) Infant or follow-on formula
MXPA06000045A (es) Formula infantil o de seguimiento
RU2013127319A (ru) Адаптированная к возрасту питательная смесь для младенцев со специально подобранной плотностью калорий

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20170619